Work

Efficacy and safety results of ramucirumab in combination with osimertinib in advanced T790M-positive EGFR-mutant NSCLC.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.9053

Authors: David Planchard, Helena Alexandra Yu, James Chih-Hsin Yang, Ki Hyeong Lee, Pilar Garrido Lopez, Keunchil Park, Joo-Hang Kim, Dae Ho Lee, Shuang He, Bo H. Chao, Luis G. Paz-Ares

Institutions: Institut Gustave Roussy, Memorial Sloan Kettering Cancer Center, National Taiwan University Hospital, Chungbuk National University Hospital, Hospital Universitario Ramón y Cajal, Samsung Medical Center, Sungkyunkwan University, CHA University Bundang Medical Center, CHA University, Asan Medical Center, University of Ulsan, Eli Lilly (United States), Hospital Universitario 12 De Octubre

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2890244190

Cites:

Cited by: 4

Related to: 10